¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Disorder of kidney and ureter, unspecified"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • shared paranoid disorder
    °øÀ¯ÆíÁýÀå¾Ö
  • single-gene disorder
    ´ÜÀÏÀ¯ÀüÀÚÁúȯ
  • sleep disorder
    ¼ö¸éÀå¾Ö
  • sleep-wake schedule disorder
    ¼ö¸é°¢¼ºÀÏÁ¤Àå¾Ö
  • sleep-wake transition disorder
    ¼ö¸é°¢¼ºÀÌÇàÀå¾Ö
  • temperature-dependent skin disorder
    ¿ÂµµÀÇÁ¸ÇǺκ´
  • unipolar disorder
    ´Ü±Ø¼ºÀå¾Ö, Ȭ±ØÀå¾Ö
  • vascular disorder
    Ç÷°üÀå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • sexual disorder
    ¼ºÀå¾Ö
  • sexual arousal disorder
    ¼ºÈïºÐÀå¾Ö
  • sexual aversion disorder
    ¼ºÇø¿ÀÀå¾Ö, ¼ºÇø¿Àº´
  • sexual desire disorder
    ¼º¿åÀå¾Ö
  • shared paranoid disorder
    °øÀ¯ÆíÁýÀå¾Ö, °øÀ¯ÆíÁýº´
  • sibling rivalry disorder
    µ¿±â°£°æÀïÀå¾Ö, µ¿±â°£°æÀﺴ
  • sleep disorder
    ¼ö¸éÀå¾Ö, ¼ö¸éº´
  • sleep-wake schedule disorder
    ¼ö¸é°¢¼ºÀÏÁ¤Àå¾Ö
  • sleep-wake transition disorder
    ¼ö¸é°¢¼ºÀÌÇàÀå¾Ö
  • somatic disorder
    ½ÅüÀå¾Ö
  • somatization disorder
    ½ÅüȭÀå¾Ö
  • somatoform disorder
    ½ÅüÇüÀå¾Ö, ½ÅüÇüº´
  • somatoform pain disorder
    ½ÅüÇüÅëÁõÀå¾Ö, ½ÅüÇüÅëÁõº´
  • stress-related disorder
    ½ºÆ®·¹½º°ü·ÃÀå¾Ö
  • sweating disorder
    ¶¡Àå¾Ö, ¹ßÇÑÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • exudative chronic discoid and lichenoid dermatitis
    »ïÃ⼺ ¸¸¼º ¿øÆÇ»ó ż±¾ç ÇǺο°
  • familial fructose and galactose intol
    °¡Á·¼º ÇÁ·°Åä¿À½º ¹× °¥¶ôÅä ¿À½º
  • familial fructose and galactose intolerance
    °¡Á·¼º ÇÁ·°Åä¿À½º ¹× °¥¶ôÅä ¿À½º ºÒ³»Àμº(¡­ÝÕÒ±ìÑàõ).
  • flexure of wrist and hand
  • fluid and hemodynamic derangements
    ü¾× ¹×, Ç÷¿ªÇÐÀå¾Ö
  • fold and fossa
    º¹¸·ÁÖ¸§°ú º¹¸·¿À¸ñ
  • foot and mouth disease
    ¹ßÀÔº´, Á·±¸º´
  • foot and mouth disease
    ±¸Àúº´
  • foot and mouth disease
    ¹ßÀÔº´, Á·±¸º´.
  • foot-and-mouth disease
    ±¸Á¦¿ª (Ï¢ð´æ¹)
  • glioma of optic nerve and chiasm
    ½Ã½Å°æ±³Â÷ ±³¼¼Æ÷Á¾.
  • glycerin and potash solution
    ±Û¸®¼¼¸° Ä®·ý¾×.
  • gray matter (nuclei and columns)
    ȸ»öÁú(½Å°æÇÙ°ú ½Å°æ±âµÕ)
  • half and half nail
    ¹Ý¹Ý Á¶°©
  • hand and foot disease
    ¼ö Á· Áúȯ£¨â¢ðëòðü´£©£¬¼Õ ¹ß º´, ¼ö Á· º´ (â¢ðëÜ»).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 15
PD Doctor of Pharmacy; Dublin Pharmacopoeia; interpupillary distance; Paget disease; pancreatic duct; p...
PDD pervasive developmental disorder; platinum diamminodichloride [cisplatin]; primary degenerative deme...
PDSRS Panic Disorder Self-Rating Scale
PHD pathological habit disorder; personal health data; post-heparin plasma diamine oxidase; potentially ...
PMDD premenstrual dysphoric disorder
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 15
AD Autistic Disorder
APD Avoidant personality disorder
BED Binge Eating Disorder
BD Bipolar Disorder
BAD Bipolar affective disorder
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • psychophysiology disorder
    Á¤½Å »ý¸® Áúȯ
  • psychosomatic disorder
    ½É½Å¼º Àå¾Ö, Á¤½Å ½Åü Áúȯ
  • reticuloendothelial disorder
    ¼¼¸Á ³»Çǰè Áúȯ
  • rheumatologic disorder
    ·ù¸¶Æ¼¼º Àå¾Ö, ·ù¸¶Æ¼½º Àå¾Ö
  • schizoaffective disorder
    ºÐ¿­ Á¤µ¿Çü Àå¾Ö
    Á¤½Å ºÐ¿­Áõ°ú °¨Á¤ Àå¾Ö, ¿¹¸¦ µé¾î Á¶ÁõÀ̳ª ¿ì¿ïÁõ µî ¾çÂÊ Áõ»óÀ» ´Ù °®°í ÀÖ´Â Á¤½Å Àå¾ÖÀÇ Áø´Ü¸í.
  • schizoid disorder
    ºÐ¿­º´ ºÎÁ¶
  • schizophreniform disorder
    Á¤½Å ºÐ¿­Çü Àå¾Ö
    Áõ»óÀ̳ª ÁõÈÄ´Â Á¤½Å ºÐ¿­ÁõÀ» °¡Áö°í ÀÖÀ¸³ª ±× ±â°£ÀÌ 6°³¿ù¿¡ ¹ÌÄ¡Áö ¸øÇÏ´Â Á¤½Å Àå¾Ö. Àü¿¡´Â ±Þ¼º Á¤½Å ºÐ¿­ÁõÀ̶ó°í ºÒ·¶´Ù.
  • secondary disorder
    ÀÌÂ÷ Àå¾Ö
  • skin disorder
    ÇǺΠÁúȯ
  • sleep terror disorder
    ¾ß°æ Àå¾Ö
    ÀáµéÀÚ °ð Àá¿¡¼­ ±ú¾î³ª °­ÇÑ ºÒ¾È°ú ÀÚÀ²½Å°æ °èÅëÀÇ Áõ»óµéÀÌ ³ªÅ¸³ª ¾Æ¹«¸® ÁøÁ¤½ÃŰ·Á ÇØµµ Àß µèÁö ¾Ê´Â »óŰ¡ µÇÇ®ÀÌÇÏ¿© ÀϾ´Â °Í.
  • somatic disorder
    ½Åü Àå¾Ö
  • somatization disorder
    ½Åüȭ Àå¾Ö
    Áø´Ü¸íÀ¸·Î, ÀüÇüÀûÀÎ È÷½ºÅ׸® ¶Ç´Â ºê¸®ÄÉ ÁõÈıºÀÌ ¾Æ´Ñ ´Ù¹ßÀû ½Åü Áõ»ó È£¼Ò°¡ Ư¡ÀÎ Á¤½Å Àå¾Ö, º´¼ÒÀÇ ³»¿ëÀº Àü¹ÝÀûÀ¸·Î ÀÚÁÖ ¿©±âÀú±â Àß ¾ÆÇÁ´Ù´Â °Í°ú °¡½Å°æÇÐÀûÀΠƯ¼öÇÑ Àüȯ Áõ»ó, ¼ÒÈ­±â°è Áõ»ó, ¿©¼º »ý½Ä±â°è Áõ»ó, Á¤½Å¼º Áõ»ó, ½ÉÆó°è Áõ»ó ¹× ÅëÁõ µîÀÌ´Ù. º´¼Ò´Â °¡²û ±ØÀûÀÌ°í ¸ðÈ£ÇÏ¸ç °úÀåµÈ ÇüÅ·ΠǥÇöµÈ´Ù. ¸¹Àº ÀÇ»çµéÀÌ ÀÌ È¯ÀÚÀÇ ÀÇÇÐÀû Ä¡·á¿¡ °³ÀԵǰí, ¼ö¾øÀÌ ¸¹Àº Áø´Ü °úÁ¤°ú ÇÊ¿ä ¾ø´Â ³»°úÀû Ä¡·á ¶Ç´Â ¼ö¼ú±îÁö ÇÏ°Ô µÈ´Ù. ´ëºÎºÐÀÇ È¯ÀÚµéÀº ºÒ¾È, ¿ì¿ï ¶Ç´Â ±¤¹üÀ§ÇÑ ´ëÀÎ °ü°èÀÇ ¾î·Á¿òÀÌ ÀÖ°í ´ëºÎºÐÀÌ È÷½ºÅ׸®¼º ÀÎ°Ý Æ¯¼ºÀ» °®°í ÀÖ´Ù.
  • somatoform disorder
    ½Åü Àå¾Ö, ½ÅüÇü Àå¾Ö, ½Åüȭ Àå¾Ö
    ±âÁúÀû ¼Ò°ßÀÌ ¾ø´Â ½Åü ÁúȯÀ» ³ªÅ¸³»´Â Áõ»óÀÌ ÀÖ´Â Á¤½ÅÀû »óÅ·μ­ ÀÓ»óÀûÀ¸·Î ÀûÀÀ¼º ±â´É¿¡ ½ÉÇÑ Àå¾ÖÀÇ ¿øÀÎÀÌ µÈ´Ù. DSM-VI´Â ÀÌ·¯ÇÑ Àå¾Ö¿¡ 5°¡Áö°¡ ÀÖ´Ù´Â °ÍÀ» ¾Ë·ÁÁØ´Ù. Áï ½Åüȭ Àå¾Ö
  • somatoform pain disorder
    ½ÅüÇü ÅëÁõ Àå¾Ö
    ÁÖµÈ È£¼Ò°¡ ½ÉÇÑ ¸¸¼º ÅëÁõÀ̰í Àüȯ Àå¾ÖÀÇ Áø´Ü ±âÁØ¿¡ ¸Â´Â °ÍÀÌ Æ¯Â¡ÀÎ Á¤½Å Àå¾Ö. ƯÈ÷, ÅëÁõÀÌ ½Å°æ ÇØºÎ³ª ÀÌ¹Ì ¾Ë·ÁÁø º´»ý¸®ÇÐÀû ±âÀü¿¡ ÀÏÄ¡µÇÁö ¾Ê°í ±âÁúÀû º´¸®ÀÇ º¯È­°¡ ÀÖ´Ù ÇÏ´õ¶óµµ ÅëÁõÀÌ ¿¹»óº¸´Ù ÈξÀ ¸¹°Å³ª ¶Ç´Â Áõ»óµéÀÌ ½É¸®Àû ¿øÀÎÀ» ¸í½ÃÇÏ´Â ÁõÈĸ¦ °®°í ÀÖ´Ù.
  • speech disorder
    ¾ð¾î Àå¾Ö
    ¸»À» ¹Ù¸£°Ô ¹ßÀ½ÇÏÁö ¸øÇϰųª Á¤È®ÇÏ°Ô ÀÌÇØÇÏÁö ¸øÇÏ´Â »óÅÂ. Àΰ£Àº ¸»
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
kidney failure, acute A clinical syndrome characterised by a sudden decrease in glomerular filtration rate, often to values of less than 1 to 2 ml per minute. It is usually associated with oliguria (urine volumes of less than 400 ml per day) and is always associated with biochemical consequences of the reduction in glomerular filtration rate such as a rise in blood urea nitrogen (bun) and serum creatinine concentrations.
(12 Dec 1998)
kidney failure, chronic An irreversible and usually progressive reduction in renal function in which both kidneys have been damaged by a variety of diseases to the extent that they are unable to adequately remove the metabolic products from the blood and regulate the body's electrolyte composition and acid-base balance. Chronic kidney failure requires haemodialysis or surgery, usually kidney transplantation.
(12 Dec 1998)
kidney: gallium imaging <radiology> 10-20% of Ga-67 excreted via GU tract; no renal activity after 24hrs abnormal uptake (images at 48-72 hrs): tumour, primary renal tumour (variable uptake), lymphoma/leukaemia, metastases (e.g., melanoma), inflammation, acute pyelonephritis (88% sensitivity); abscess, lobar nephroma, others, collagen vascular disease, vasculitis, Wegener granulomatosis, amyloidosis, haemochromatosis, hepatic failure, antineoplastic drugs, transplant rejection: acute, chronic, ATN see also: gallium: indications
(12 Dec 1998)
kidney glomerulus Globular tufts of capillaries, one projecting into the expanded end or capsule of each of the uriniferous tubules, which together with its surrounding capsule (glomerular capsule) constitute the renal corpuscle.
(12 Dec 1998)
kidney medulla The internal portion of the kidney, consisting of striated conical masses, the renal pyramids, whose bases are adjacent to the cortex and whose apices form prominent papillae projecting into the lumen of the minor calyces.
(12 Dec 1998)
kidney neoplasms Neoplasms or tumours of the kidney. Renal cell carcinoma is the most common neoplastic lesion of the kidney, accounting for approximately 85% of all kidney neoplasms. The vast majority of these tumours are adenocarcinoma.
(12 Dec 1998)
kidney papillary necrosis A form of acute kidney disease characterised by necrosis of the renal papillae. It is most frequently associated with diabetes mellitus because of the severe vascular disease present in the arteries and capillaries, particularly in the kidney. There is usually a large component of infection present, and in non-diabetics pyelonephritis and obstructive uropathy are the usual aetiologic agents.
(12 Dec 1998)
kidney pelvis The expansion from the upper end of the ureter into which the calices of the kidney (kidney calices) open.
(12 Dec 1998)
kidney plasminogen activator <protein> A precursor to the enzyme urokinase that has blood clotting properties.
(14 Nov 1997)
kidney, polycystic Kidney whose tissue is displaced by a large number of tightly packed cysts so that cystic volume predominates over the solid parts to a considerable degree.
(12 Dec 1998)
kidney, polycystic, autosomal dominant A genetic disorder with autosomal dominant inheritance characterised by multiple cysts in both kidneys and progressive deterioration of renal function. It is usually caused by a mutant gene at the pkd1 locus on the short arm of chromosome 16, though mutations elsewhere in the genome can also cause the disease. The age of onset of symptoms varies widely.
(12 Dec 1998)
kidney, polycystic, autosomal recessive Rare genetic disorder with autosomal recessive inheritance characterised by multiple cysts in both kidneys and associated hepatic lesions. Serious manifestations are usually present at birth and there is high perinatal mortality.
(12 Dec 1998)
kidney profile <investigation> A test which includes the measurement of the blood urea nitrogen (BUN) and the creatinine in a venous specimen. This test allows the physician to make a determination of how effectively the kidneys are functioning.
(27 Sep 1997)
kidney-shaped Having the form or shape of a kidney; reniform; as, a kidney-shaped leaf.
(01 Mar 1998)
kidney, sponge Cystic disease of the medullary portion of the renal pyramids; asymptomatic unless complicated by infection, calculi, or obstruction; should be distinguished from congenital polycystic disease of the kidneys.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 15
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 15
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 15
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 15
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 15
ÅëÇÕ°Ë»ö ¿Ï·á